Screener
Wave Life Sciences WVE Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Wave Life Sciences’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324949
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Cash flows from investing activities | ||
| Purchases of property and equipment | (1,322) | (471) |
| Purchases of marketable securities | (122,570) | — |
| Net cash used in investing activities | (123,892) | (471) |
| Cash flows from financing activities | ||
| Proceeds from issuance of ordinary shares pursuant to the “at-the-market” equity program, net of offering costs | — | 12,361 |
| Proceeds from the exercise of share options | 2,264 | 3,045 |
| Proceeds from the ESPP | 593 | 442 |
Item 1. Financial Statements
FAQ
- What is Wave Life Sciences's investing cash flow?
- Wave Life Sciences (WVE) reported investing cash flow of -$123.45M in Q2 2026.
- How has Wave Life Sciences's investing cash flow changed year-over-year?
- Wave Life Sciences's investing cash flow decreased by 40244.4% year-over-year, from -$306K to -$123.45M.
- What is the long-term trend for Wave Life Sciences's investing cash flow?
- Over 3 years (2021 to 2025), Wave Life Sciences's investing cash flow has grown at a 8.7% compound annual growth rate (CAGR), from -$560K to -$719K.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Wave Life Sciences's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude